Accuray (ARAY) and the University of Wisconsin School of Medicine and Public Health announced the signing of a memorandum of understanding to advance online adaptive radiotherapy on the Accuray helical radiation treatment delivery platform. As part of the MOU, the two parties outlined their intent to collaborate on clinical research, education and training, and adaptive technology development, to help empower medical care teams to raise the bar in the personalization and precision of cancer care.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARAY:
- Accuray Announces Consulting Agreement with Departing Executive
- Accuray’s Earnings Call: Growth Amid Challenges
- Accuray Faces Stock Dilution Risk as Warrant Exercises Loom, Threatening Share Value
- Accuray Announces Leadership Changes Amid Executive Departures
- Accuray price target raised to $5 from $4 at BTIG